Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06646445 |
| Title | Neoadjuvant Pembrolizumab with a Watch-and-wait Strategy for Patients with DMMR/MSI-H Localized Colon Cancer: GERCOR G-109 PRODIGE 84 PREMICES Phase II Trial (PREMICES) |
| Acronym | PREMICES |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | GERCOR - Multidisciplinary Oncology Cooperative Group |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Institut Sainte Catherine | Avignon | France | Details | |||
| CHU Besançon | Besançon | France | Details | |||
| IHFB Cognacq Jay | Levallois Perret | France | Details | |||
| Centre Leon Berard | Lyon | France | Details | |||
| Groupe Hospitalier Diaconesses Croix Saint Simon | Paris | France | Details | |||
| Hôpital Saint Antoine | Paris | France | Details | |||
| Institut Mutualiste Montsouris | Paris | France | Details | |||
| CHU Bordeaux Haut Lévêque | Pessac | France | Details | |||
| CHU Poitiers | Poitiers | France | Details | |||
| CHU Toulouse | Toulouse | France | Details |